Central Drugs Laboratory, Kolkata and Regional Drugs Testing Laboratory, Chandigarh had analysed 156 samples drawn by drug inspectors of Central Drugs Standard Control Organisation (CDSCO) from different locations in the state in connection with the supply of spurious drugs in the government-run hospitals.
An official in the Drug Controller Department Jammu said the department has taken action after the report came and various drugs have been seized, even as the inquiry is on.
In their report to CDSCO, the laboratories have listed 24 medicines, including two taken from the premier healthcare institute in the Valley - SKIMS, as sub-standard.
The laboratories found the samples of Injection Amoxicillin and Potassium Clavulenate taken from SKIMS and manufactured by a Karnataka based company as sub-standard and having the presence of particulate matter, the report said.
Similarly, the analysis of another drug from the same institute, Injection Zepoxin, manufactured by a Mumbai based company, showed no clarity of the solution and presence of particulate matter, it said.
The samples of the drug Clonazepam 1 mg taken from the Valley's only psychiatric hospital here also turned out to be sub-standard, the report mentions.
The laboratories also found that spurious drugs were being sold in chemist shops across the state, as many samples, taken from such shops in Pulwama, Udhampur, Srinagar and Kishtwar were found to be sub-standard.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
